Literature DB >> 23851396

Structural basis for molecular recognition of folic acid by folate receptors.

Chen Chen1, Jiyuan Ke, X Edward Zhou, Wei Yi, Joseph S Brunzelle, Jun Li, Eu-Leong Yong, H Eric Xu, Karsten Melcher.   

Abstract

Folate receptors (FRα, FRβ and FRγ) are cysteine-rich cell-surface glycoproteins that bind folate with high affinity to mediate cellular uptake of folate. Although expressed at very low levels in most tissues, folate receptors, especially FRα, are expressed at high levels in numerous cancers to meet the folate demand of rapidly dividing cells under low folate conditions. The folate dependency of many tumours has been therapeutically and diagnostically exploited by administration of anti-FRα antibodies, high-affinity antifolates, folate-based imaging agents and folate-conjugated drugs and toxins. To understand how folate binds its receptors, we determined the crystal structure of human FRα in complex with folic acid at 2.8 Å resolution. FRα has a globular structure stabilized by eight disulphide bonds and contains a deep open folate-binding pocket comprised of residues that are conserved in all receptor subtypes. The folate pteroate moiety is buried inside the receptor, whereas its glutamate moiety is solvent-exposed and sticks out of the pocket entrance, allowing it to be conjugated to drugs without adversely affecting FRα binding. The extensive interactions between the receptor and ligand readily explain the high folate-binding affinity of folate receptors and provide a template for designing more specific drugs targeting the folate receptor system.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23851396      PMCID: PMC5797940          DOI: 10.1038/nature12327

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  26 in total

1.  Refinement of macromolecular structures by the maximum-likelihood method.

Authors:  G N Murshudov; A A Vagin; E J Dodson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-05-01

Review 2.  Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy.

Authors:  Hala Elnakat; Manohar Ratnam
Journal:  Adv Drug Deliv Rev       Date:  2004-04-29       Impact factor: 15.470

3.  Synthesis and biological activity of a novel series of 6-substituted thieno[2,3-d]pyrimidine antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors over the reduced folate carrier and proton-coupled folate transporter for cellular entry.

Authors:  Yijun Deng; Xilin Zhou; Sita Kugel Desmoulin; Jianmei Wu; Christina Cherian; Zhanjun Hou; Larry H Matherly; Aleem Gangjee
Journal:  J Med Chem       Date:  2009-05-14       Impact factor: 7.446

4.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

5.  Folate-mediated drug delivery: effect of alternative conjugation chemistry.

Authors:  C P Leamon; R B DePrince; R W Hendren
Journal:  J Drug Target       Date:  1999       Impact factor: 5.121

Review 6.  Folate metabolism and requirements.

Authors:  L B Bailey; J F Gregory
Journal:  J Nutr       Date:  1999-04       Impact factor: 4.798

7.  A role for the proton-coupled folate transporter (PCFT-SLC46A1) in folate receptor-mediated endocytosis.

Authors:  Rongbao Zhao; Sang Hee Min; Yanhua Wang; Estela Campanella; Philip S Low; I David Goldman
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

8.  Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay.

Authors:  Nikki Parker; Mary Jo Turk; Elaine Westrick; Jeffrey D Lewis; Philip S Low; Christopher P Leamon
Journal:  Anal Biochem       Date:  2005-03-15       Impact factor: 3.365

9.  Preclinical antitumor activity of a novel folate-targeted dual drug conjugate.

Authors:  Christopher P Leamon; Joseph A Reddy; Iontcho R Vlahov; Elaine Westrick; Alicia Dawson; Ryan Dorton; Marilynn Vetzel; Hari Krishna Santhapuram; Yu Wang
Journal:  Mol Pharm       Date:  2007-09-18       Impact factor: 4.939

10.  Experimental phasing with SHELXC/D/E: combining chain tracing with density modification.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24
View more
  144 in total

1.  Polysaccharide-Based Nanoparticles for Two-Step Responsive Release of Antitumor Drug.

Authors:  Hong-Guang Fu; Yong Chen; Qilin Yu; Yu Liu
Journal:  ACS Med Chem Lett       Date:  2020-05-18       Impact factor: 4.345

2.  6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Regioisomers as Targeted Antifolates for Folate Receptor α and the Proton-Coupled Folate Transporter in Human Tumors.

Authors:  Lei Wang; Adrianne Wallace; Sudhir Raghavan; Siobhan M Deis; Mike R Wilson; Si Yang; Lisa Polin; Kathryn White; Juiwanna Kushner; Steven Orr; Christina George; Carrie O'Connor; Zhanjun Hou; Shermaine Mitchell-Ryan; Charles E Dann; Larry H Matherly; Aleem Gangjee
Journal:  J Med Chem       Date:  2015-08-28       Impact factor: 7.446

3.  Ligand-decorated click polypeptide derived nanoparticles for targeted drug delivery applications.

Authors:  Mohiuddin A Quadir; Stephen W Morton; Lawrence B Mensah; Kevin Shopsowitz; Jeroen Dobbelaar; Nicole Effenberger; Paula T Hammond
Journal:  Nanomedicine       Date:  2017-03-02       Impact factor: 5.307

4.  Tumor-targeting with novel non-benzoyl 6-substituted straight chain pyrrolo[2,3-d]pyrimidine antifolates via cellular uptake by folate receptor α and inhibition of de novo purine nucleotide biosynthesis.

Authors:  Yiqiang Wang; Christina Cherian; Steven Orr; Shermaine Mitchell-Ryan; Zhanjun Hou; Sudhir Raghavan; Larry H Matherly; Aleem Gangjee
Journal:  J Med Chem       Date:  2013-10-30       Impact factor: 7.446

5.  Development and validation of chemical features-based proton-coupled folate transporter/activity and reduced folate carrier/activity models (pharmacophores).

Authors:  Khushbu Shah; Sudhir Raghavan; Zhanjun Hou; Larry H Matherly; Aleem Gangjee
Journal:  J Mol Graph Model       Date:  2018-02-20       Impact factor: 2.518

6.  Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery.

Authors:  Leyuan Xu; W Andrew Yeudall; Hu Yang
Journal:  Acta Biomater       Date:  2017-04-22       Impact factor: 8.947

Review 7.  One-carbon metabolism and folate transporter genes: Do they factor prominently in the genetic etiology of neural tube defects?

Authors:  John W Steele; Sung-Eun Kim; Richard H Finnell
Journal:  Biochimie       Date:  2020-02-13       Impact factor: 4.079

8.  Recruiting cytotoxic T cells to folate-receptor-positive cancer cells.

Authors:  Sumith A Kularatne; Vishal Deshmukh; Marco Gymnopoulos; Sandra L Biroc; Jinming Xia; Shaila Srinagesh; Ying Sun; Ning Zou; Mark Shimazu; Jason Pinkstaff; Semsi Ensari; Nick Knudsen; Anthony Manibusan; Jun Axup; Chanhyuk Kim; Vaughn Smider; Tsotne Javahishvili; Peter G Schultz
Journal:  Angew Chem Int Ed Engl       Date:  2013-09-25       Impact factor: 15.336

9.  Characterization of Folic Acid and Poly(amidoamine) Dendrimer Interactions with Folate Binding Protein: A Force-Pulling Study.

Authors:  Pascale R Leroueil; Stassi DiMaggio; Abigail N Leistra; Craig D Blanchette; Christine Orme; Kumar Sinniah; Bradford G Orr; Mark M Banaszak Holl
Journal:  J Phys Chem B       Date:  2015-08-14       Impact factor: 2.991

10.  Tumor Targeting with Novel 6-Substituted Pyrrolo [2,3-d] Pyrimidine Antifolates with Heteroatom Bridge Substitutions via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis.

Authors:  Lalit K Golani; Adrianne Wallace-Povirk; Siobhan M Deis; Jennifer Wong; Jiyuan Ke; Xin Gu; Sudhir Raghavan; Mike R Wilson; Xinxin Li; Lisa Polin; Parker W de Waal; Kathryn White; Juiwanna Kushner; Carrie O'Connor; Zhanjun Hou; H Eric Xu; Karsten Melcher; Charles E Dann; Larry H Matherly; Aleem Gangjee
Journal:  J Med Chem       Date:  2016-08-26       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.